Bill Jellison

Track

Insider profile

Currently holds a position at Avient Corp

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 51% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Avient Corp Oct. 7, 2015 -
Chief Financial Officer, Vice President Stryker Corporation April 22, 2013 - April 1, 2016
Chief Financial Officer, Senior Vice President DENTSPLY SIRONA Inc Jan. 10, 2005 - April 5, 2013
Bill Jellison's trades of Anika Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
61.32
Quantity 81,629 -26.5%
Value US$1,323,914
Transaction date
Purchase
Price
27.56
Quantity 21,389 -22.5%
Value US$4,648,616
US Masimo Corp (MASI)
Transaction date
Purchase
Price
145.98
Quantity 3,000 +167.6%
Value US$437,940
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-07
PrS Proposed sale
77,793
42.76
US$3,961,063 		77,793 42.76 US$3,961,063
2025-08-25 2025-08-25
B Purchase
81,629 -26.5%
61.32
US$1,323,914 		81,629 -26.5% 61.32 US$1,323,914
2025-08-25 2025-08-22
B Purchase
21,389 -22.5%
27.56
US$4,648,616 		21,389 -22.5% 27.56 US$4,648,616
2025-08-12 2025-08-11
US Masimo Corp (MASI)
B Purchase
3,000 +167.6%
145.98
US$437,940 		3,000 +167.6% 145.98 US$437,940